Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines.

Brucella abortus may be useful as a component of vaccines. This is because it possesses several unique properties as a carrier that enable it to stimulate human B cells even in the relative absence of T cells. Human immunodeficiency virus type 1 proteins conjugated to B. abortus could induce neutral...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Goldstein, J, Hoffman, T, Frasch, C, Lizzio, E F, Beining, P R, Hochstein, D, Lee, Y L, Angus, R D, Golding, B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1992
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC257008/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1548064/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.60.4.1385-1389.1992
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!